Primary leiomyosarcoma of the right atrium: a case report and literature update
© Parissis et al; licensee BioMed Central Ltd. 2010
Received: 10 June 2010
Accepted: 12 October 2010
Published: 12 October 2010
Leiomyosarcoma of the right atrium is a very rare cardiac tumor. Various combinations of treatments including resection or transplant surgery and Chemotherapy have been advocated. We report a case of a man who presented with pulmonary embolism secondary to right atrial leiomyosarcoma. He was managed by excision of the tumor and reconstruction of the right atrium with autologous pericardium. Postoperatively tumor dissemination was controlled with adjuvant chemotherapy.
A vigorous attempt aiming at tumor clearance followed by adjuvant multimodality therapy along with a tumor surveillance program may improve survival.
Primary cardiac malignancies (PCM) are rare. The prevalence of primary cardiac malignancies has been estimated at only 0.001% - 0.28% . Primary cardiac tumors are detected in 1 in a 1000 autopsies and PCM are found in only about 0.0017% of autopsies [2, 3]. Metastatic cardiac tumors are a 100-fold more common than primary lesions. The majority of Primary Cardiac tumors are benign (with half of them being myxomas)  and approximately 25% of primary cardiac neoplasms are malignant. Among malignant primary cardiac tumors, the most reported are those histopathologically considered as undifferentiated, followed by angiosarcomas with leiomyosarcomas being rare. Due to delayed presentation there is infrequently, a systemic spread at the time of diagnosis. As a result management of this condition is difficult and controversial.
Although resection margins were clear the margin width was deemed to be inadequate. After recovery from surgery the patient was submitted to chemotherapy with Doxirubicin and Isofomaide. A tumor surveillance plan involving serial echocardiograms is planned.
Of the few hundred cases of malignant tumors of the heart reported, most have been based on autopsy series. Moreover, throughout the last 30 years literature from a 100 plus articles on cardiac neoplasms, only few publications are reporting on primary cardiac malignancies .
Cardiac sarcomas are the second most common type of primary cardiac neoplasms with Leiomyosarcomas to consist of 8% of cardiac sarcomas [6, 7]. As per Kim et al  angiosarcomas and unclassified sarcomas are the most common sarcomas of the heart accounting for 76%of the cases, with leiomyosarcomas being a minority. There is a wide age and size range with a slight female predilection. As per Zhang et al  the sarcoma arises in the atria/pulmonary vessels in 74% of the cases, and in the ventricles, mitral valve, and epi/pericardium in 14%, 3.7% and 7.4% of the cases correspondingly. There is probably a slight left side predilection. In contrary, predominantly right side distribution is given in other reports  with right atrial involvement being 58% and left atrial 25% of the cases.
Leiomyosarcoma favors the left atrium and most likely originates from pulmonary vein smooth muscles and present as a left atrial tumor. Affected patients typically present in the 4th decade of life which is slightly younger than the average age at presentation for cardiac sarcoma patients. Unlike angiosarcomas hemorrhage is unusual. Those tumors are likely to involve the mitral valve and extend into the pulmonary veins and therefore present with pulmonary congestion. Macroscopically the tumor appears as gelatinous mass and maybe multiple in up to 30% of the cases .
In our case report the site of origin of the tumor was the right atrium which is rare. The presentation was consistent with thromboembolic phenomenon commonly associated with this tumor site. Other possible presentations include progressive or sudden right sided cardiac failure on the account of tricuspid valve blockage by the tumor or paroxysmal atrial arrhythmias. Broadly speaking, cardiac tumors produce a large variety of symptoms through any of 4 mechanisms. Their mass can obstruct intracardiac blood flow or interfere with valve function. Local invasion can lead to arrhythmias or pericardial effusions with tamponade. Bits of tumor can embolize, causing systemic deficits when the tumors are on the left side of the heart. Finally, the tumors may cause systemic or constitutional symptoms.
Echocardiographic imaging is the most sensitive imaging technique with ability to identify tumors as small as 3 mm. However, soft-tissue characterization remains limited compared with that achieved with computed tomography (CT) and magnetic resonance (MR) imaging, and myocardial disease such as tumor infiltration is not clearly depicted . On the other hand with MRI or contrast enhanced CT the tumor has to be around 1 cm in size before becoming detectable.
In this case CT scan raised the suspicion of intracardiac tumor by depicting a low attenuation filling defect and echocardiography confirmed the diagnosis. A preoperative tissue diagnosis was not attempted due to the emergent presentation. However atypical appearance of the right atrium and of the tumor raised the suspicion of malignancy and frozen section examination was confirmatory. It has been recommended that all atrial tumors should be subjected to frozen section examination in order to ensure optimum surgical resection.
According to Mayer et al half the patients with cardiac sarcomas, are presented with high grade tumors and distant metastases: lungs 35.7%, lymph nodes 14.2%, and liver 7.14%. Tumor spread from primary cardiac sarcoma to the bone is very rare and has a poor prognosis. Only six cases have been reported in the literature . Furthermore, from the patients that are deemed suitable for surgery, complete macroscopic resection is only possible in 33% .
Operative mortality has been reported to be high at 8.3% with an overall actuarial survival of 14% at 24 months after resection . Likewise other groups [8, 12] have reported poor prognosis with a median survival time of 25 months after diagnosis.
As per Burke et al , the survival rate on univariate analysis was more favorable for patients with tumors located on the left side of the heart, without necrosis, with a low mitotic count, and without metastasis at diagnosis. By multivariate analysis, a low level of mitotic activity and any therapy were the only significant factors affecting survival rate. Furthermore tumor grade, unlike histological type, appears to be prognostically important in cardiac sarcoma .
The optimum treatment of Leiomyosarcoma is not known. Of the several reports in the literature, patients subjected to multimodality treatment including heart transplantation (The most common cause of death is local recurrence of the tumors in 50% of the cases ) have longer survival.
We adopted a strategy that would ensure local control of the tumor by surgical resection and address systemic spread by adjuvant chemotherapy. Tumor shrinkage can be achieved by chemotherapy prior to surgery in non emergency setting. Given the high risk of tumor recurrence we plan to follow-up the patient with serial echocardiographic scans with the view to further surgical or chemotherapeutic intervention aimed at early treatment of recurrence.
In conclusion PCM are rare and will always pose a diagnostic dilemma. Nevertheless, atypical presentation of suspected "atrial myxoma" should raise the possibility of rare atrial tumors. Unfortunately, almost half of those tumors have metastasized at presentation, up to 30% could be multifocal and the rest may be amenable to surgery. All such tumors should be subjected to frozen section examination intraoperatively.
Surgery carries a high mortality and the overall long survival was only achieved in patients who survived the initial surgery well.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for the review by the Editor-in-Chief of this journal.
- Engberding R, Daniel WG, Erbel R: Diagnosis of heart tumours by transoesophageal echocardiography: a multicentre study in 154 patients. Eur Heart J. 1993, 14: 1223-8. [Medline]View ArticlePubMedGoogle Scholar
- Basso C, Valente M, Poletti A, Casarotto D, Thiene G: Surgical pathology of primary cardiac and pericardial tumors. Eur J Cardiothorac Surg. 1997, 12 (5): 730-7. 10.1016/S1010-7940(97)00246-7. discussion 737-8View ArticlePubMedGoogle Scholar
- Castillo JG, Silvay G: Characterization and management of cardiac tumors. Cardiothorac Vasc Anesth. 2010, 14 (1): 6-20. 10.1177/1089253210362596.View ArticleGoogle Scholar
- Patel J, Sheppard MN: Pathological study of primary cardiac and pericardial tumors in a specialist UK Centre: surgical and autopsy series. Cardiovasc Pathol. 2009Google Scholar
- Neragi-Miandoab S, Kim J, Vlahakes GJ: Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol). 2007, 19 (10): 748-56.View ArticleGoogle Scholar
- Zhang PJ, Brooks JS, Goldblum JR, Yoder B, Seethala R, Pawel B, Gorman JH, Gorman RC, Huang JH, Acker M, Narula N: Primary cardiac sarcomas: a clinicopathologic analysis of a series with follow-up information in 17 patients and emphasis on long-term survival. Hum Pathol. 2008, 39 (9): 1385-95. 10.1016/j.humpath.2008.01.019.View ArticlePubMedPubMed CentralGoogle Scholar
- Vander Salm TJ: Unusual primary tumors of the heart. Semin Thorac Cardiovasc Surg. 12 (2): 89-100.
- Kim CH, Dancer JY, Coffey D, Zhai QJ, Reardon M, Ayala AG, Ro JY: Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institution experience. Hum Pathol. 2008, 39 (6): 933-8. 10.1016/j.humpath.2007.12.018.View ArticlePubMedGoogle Scholar
- Araoz P, Eklund H, Welch T, Breen J: CT and MR imaging of primary cardiac malignancies. RadioGraphics. 1999, 19: 1421-1434.View ArticlePubMedGoogle Scholar
- Mayer F, Aebert H, Rudert M, Königsrainer A, Horger M, Kanz L, Bamberg M, Ziemer G, Hartmann JT: Primary malignant sarcomas of the heart and great vessels in adult patients--a single-center experience. Oncologist. 2007, 12 (9): 1134-42. 10.1634/theoncologist.12-9-1134.View ArticlePubMedGoogle Scholar
- Strina C, Zannoni M, Parolin V, Cetto GL, Zuliani S: metastases from primary cardiac sarcoma: case report. Tumori. 2009, 95 (2): 251-3.PubMedGoogle Scholar
- Donsbeck AV, Ranchere D, Coindre JM, Le Gall F, Cordier JF, Loire R: Primary cardiac sarcomas: an immunohistochemical and grading study with long-term follow-up of 24 cases. Histopathology. 1999, 34 (4): 295-304. 10.1046/j.1365-2559.1999.00636.x.View ArticlePubMedGoogle Scholar
- Putnam JB, Sweeney MS, Colon R, Lanza LA, Frazier OH, Cooley DA, cardiac sarcomas: Ann Thorac Surg. 1991, 51 (6): 906-10. 10.1016/0003-4975(91)91003-E.View ArticlePubMedGoogle Scholar
- Burke AP, Cowan D, Virmani R: Primary sarcomas of the heart. Cancer. 1992, 69 (2): 387-95. 10.1002/1097-0142(19920115)69:2<387::AID-CNCR2820690219>3.0.CO;2-N.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.